Advertisement

Prostate Cancer Urology

IsoPSA Shows Notable Diagnostic Accuracy in Detecting Prostate Cancer

Jul 20, 2022

The IsoPSA biomarker displays superior diagnostic accuracy in the early detection of prostate cancer, thereby helping to avoid unnecessary prostate biopsies. There is a growing population of pa...

[DNA repair gene alterations testing in prostate cancer : A practical update by the prostate cancer committee of the french association of urology].

Mar 07, 2022

Current therapeutic developments in prostate cancer (PCa) tend to increasingly personalize the treatment strategy, in particular as a function of tumor genomics. Recently, poly ADP-ribose polymerase (...

Evaluation of a urology specialist therapeutic radiographer implemented radiotherapy pathway for prostate cancer patients.

Oct 04, 2021

The role of the Urology Specialist Therapeutic Radiographer (USTR) was introduced to support a busy NHS uro-oncology practice. Key objectives were to improve patient preparedness for and experience of...

Clinical significance and risk factors of International Society of Urological Pathology (ISUP) grade upgrading in prostate cancer patients undergoing robot-assisted radical prostatectomy.

Aug 12, 2021

The objective of this study is to investigate the clinical significance and risk factors of upgrading in the International Society of Urological Pathology (ISUP) Grade Group System in men undergoing r...

Prostatic Urethral Lift Compared With Other Treatments

May 31, 2021

“Whenever a new medical technology is introduced—such as prostatic urethral lift (PUL) for benign prostatic enlargement and lower urinary tract symptoms (BPE/LUTS)—it is important to understand ...

Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer-2019 Updates.

May 03, 2021

To update the Hong Kong Urological Association-Hong Kong Society of Uro-Oncology consensus statements on the management of advanced prostate cancer, the same panelists as in the previous consensus pan...

Physician preferences for non-metastatic castration-resistant prostate cancer treatment.

Mar 22, 2021

Recent approvals of second-generation androgen receptor inhibitors (SGARIs) have changed the treatment landscape for non-metastatic castration-resistant prostate cancer (nmCRPC). These SGARIs have sim...

Clinical and Surgical Assistance in Prostate Cancer during the COVID-19 Pandemic: Implementation of assistance protocols.

Mar 01, 2021

Propose an approach of prostate cancer (PCa) patients during COVID-19 pandemic.We conducted a review of current literature related to surgical and clinical management of patients during COVID-19 crisi...

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART II.

Mar 01, 2021

The summary presented herein represents Part II of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients w...

Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.

Mar 01, 2021

The summary presented herein represents Part I of the two-part series dedicated to Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline discussing prognostic and treatment recommendations for patients wi...

Comparison of the Upgrading Rates of International Society of Urological Pathology Grades and Tumor Laterality in Patients Undergoing Standard 12-Core Prostate Biopsy versus Fusion Prostate Biopsy for Prostate Cancer.

Feb 25, 2020

Histopathological discrepancies between biopsy and radical prostatectomy (RP) specimens may lead to unnecessary, excessive, or incomplete treatment in prostate cancer (PCa) patients.To compare the upg...